N-(4-(1H-pyrazol-1-yl)benzyl)-6-(imidazo[1,2-a]pyridin-3-yl)pyrimidin-4-amine

ID: ALA4878220

PubChem CID: 155587747

Max Phase: Preclinical

Molecular Formula: C21H17N7

Molecular Weight: 367.42

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1ccn2c(-c3cc(NCc4ccc(-n5cccn5)cc4)ncn3)cnc2c1

Standard InChI:  InChI=1S/C21H17N7/c1-2-10-27-19(14-23-21(27)4-1)18-12-20(25-15-24-18)22-13-16-5-7-17(8-6-16)28-11-3-9-26-28/h1-12,14-15H,13H2,(H,22,24,25)

Standard InChI Key:  WXYMPBAANFTNQL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    9.6577   -5.6914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6577   -6.5086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3630   -6.9131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3630   -5.2787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0807   -5.7534    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0727   -6.5051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8480   -6.7523    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3227   -6.0914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8407   -5.4358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0582   -4.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8508   -4.4459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0694   -3.6593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4963   -3.0755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7017   -3.2836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4869   -4.0699    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.8607   -3.4551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4331   -4.0383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2244   -3.8341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7935   -4.4164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5841   -4.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8036   -3.4247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2263   -2.8403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4379   -3.0470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5916   -3.2226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2166   -3.7410    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.9036   -3.3053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7015   -2.5172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8896   -2.4660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  9 10  1  0
 12 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4878220

    ---

Associated Targets(Human)

KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 367.42Molecular Weight (Monoisotopic): 367.1545AlogP: 3.59#Rotatable Bonds: 5
Polar Surface Area: 72.93Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.29CX LogP: 2.67CX LogD: 2.66
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.51Np Likeness Score: -2.36

References

1. Abdel-Magid AF..  (2021)  The Potential of c-KIT Kinase inhibitors in Cancer Treatment.,  12  (8.0): [PMID:34413937] [10.1021/acsmedchemlett.1c00332]

Source